Description: Do you know how you would handle yourself in a high visibility situation that put your professionalism in the spotlight? How would you handle being reported to the ABCD? Hear how, Tom Dlouhy, after taking a new assignment, quickly found himself challenged from many angles but came out a stronger actuary. This lunch session is a reprise of a presentation from the 2017 Seattle Life and Annuity Symposium with some new highlights. Hear Tom share his experience with the ASOPs, the ABCD, and how he attempted to maintain the high standards of actuarial professionalism.

Description: The use of longevity swaps are an area of growing interest in North America for insurers and pension schemes to manage their exposure to longevity risk. This growth is anticipated to continue as a consequence of the increased experience in the market and this maturity will encourage an improved affordability and ability for insurers to be flexible in this space. In Europe and Asia, longevity swaps are a much more established tool for risk transfer and optimizing asset-liability matching. From these markets, we can learn how to establish an effective framework in order to price, implement, and monitor performance of longevity swaps. By attending the session, you will be informed on the typical structure and modeling/valuation approach for longevity swaps including: - Understand longevity swap concepts, their benefits and common use. - Establish a basis for assessment such asmeasurement metrics, risk factors, and benchmarking principles. - Comprehend ongoing management such as basis risk, trigger points/pull-out clauses, potential operational issues, and asset transfer mechanisms. - Understand considerations and approach for valuing under US STAT and US GAAP.

Description: Take part in an interactive session where experts from a variety of backgrounds and disciplines debate hot topics in underwriting and the impact they may have on key business outcomes such as mortality. Cast the deciding vote on each question. The debate will cover topics such as: - Leading performance indicators - are we measuring the right things? - Is the ground shifting beneath us? Less obvious, tertiary factors that could influence mortality - How much is too much? How far can we push the envelope on qualification with limited evidence? By attending the session, you will: - Identify key questions to consider relative to the continuing evolution of underwriting. - Recognize pros and cons to solutions currently in production or under consideration. - Understand potential business impacts of forthcoming underwriting changes and levers that could increase or reduce their magnitude.

Description: With recent and continuing changes in regulatory requirements under VM-20, new accounting standards under GAAP LDTI/IFRS 17, expansion of accelerated underwriting programs and digital distribution, and the impact of COVID-19, the needs and challenges being faced by life insurance companies are greater and more varied than ever. Both under favorable and stressed conditions, companies heavily rely on reinsurance and the market has seen several major transactions enacted in this space over recent months. Reinsurance offers a wider variety of opportunities for companies to manage their balance sheets and increase their return on capital. Find out how reinsurance can be utilized to address the challenges associated with earnings growth and volatility, risk management, capital allocation efficiency, and product performance optimization. Moreover, upon enacting a transaction, ensuring the implementation of effective reinsurance operations is crucial to avoid operational inefficiencies and monitor the transaction's performance. Understanding the potential opportunities and common pitfalls in the reinsurance processes is vital for capturing the full value of reinsurance. By attending the session, you will be able to understand the various challenges being faced by direct writing companies today and where reinsurance can be leveraged to improve capital and tax position, as well as achieving the optimal balance of risk appetite and underwriting profit. Additionally, the presentation will provide real life case studies on how innovation and operational excellence can improve earnings by reducing costs related to inefficiencies, reducing process timing, improving controls, and reducing reinsurance leakage.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: ClubVita Session Series Buyouts and indemnity swaps remove all the longevity risk from an underlying population. However, they can be difficult to unwind and are not very flexible or widely tradable. Explore the characteristics and product structures of indexed based longevity swaps, demonstrating how they can cover any term, how they hedge the key component of trend risk and how, with new technology developments, they could lead to a liquid market.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: Discover the rapidly developing health and wellness industry during the Use of Health and Wellness Data in L&H Risk Assessment webcast. Our discussion includes the maximization of data usage through several different means, including current risk selection, creation of a dynamic ongoing assessment offering or substitution of traditional underwriting information to shorten the underwriting process. Come explore these different approaches as they affect the health and wellness industry. We will express the importance of a constantly changing data usage environment in order to better prepare insurers to maximize their data and drive health and wellness forward.

Description: Reinsurance has become more frequently used in the annuity market along with large M&A transactions over the past few years. Discuss the market forces and the impact to the product development and pricing. By attending the session, you will: Understand the benefits of reinsuring annuities and the types of reinsurance used for annuities.

Description: Both under favorable and stressed conditions, companies heavily rely on reinsurance and the market has seen a number of major transactions enacted in this space over recent months. Reinsurance offers a wider variety of opportunities in order to manage stressed balance sheets and enhance return on capital, upon which insurers must continually reflect in order to capture all the potential value. For example, captive reinsurance, which offers expense or cost reduction advantages in addition to risk management and control, is becoming more widespread as more U.S. jurisdictions allow parents companies to benefit from these captive formations. Upon enacting a transaction, ensuring the implementation of effective reinsurance operations is crucial in order to avoid operational inefficiencies and monitor the transaction's performance. Understanding the potential opportunities and common pitfalls in reinsurance processes is vital for capturing the full value of reinsurance. By attending the session, you will: Explore all the options available where reinsurance can be leveraged to improve capital and tax position, as well as achieving the optimal balance of risk appetite and underwriting profit. Furthermore, the presentation will provide real life case studies on how innovation and operational excellence can improve earnings by reducing costs related to inefficiencies, reducing process timing, improving controls, and reducing reinsurance leakage.